Vitamin-C-megaskorbicka-liecba.pdf - Zdravie.sk

Vitamín C a megaskorbická liečba – zabudnutý poklad 421 / 436
Zdroje
[1898] Public Library of Science. The Tamiflu Story Continued: Full Reports from Clinical Trials Should Be Made
Publicly Available, Experts Argue. ScienceDaily. 2012 Apr 10.
http://www.sciencedaily.com/releases/2012/04/120410210946.htm
[1899] Doshi P, Jefferson T, Del Mar C. The imperative to share clinical study reports: recommendations from the
tamiflu experience. PLoS Med. 2012 Apr;9(4):e1001201. Epub 2012 Apr 10. PMID:22505850.
PMCID:PMC3323511. DOI:10.1371/journal.pmed.1001201.
1900
[1900] Eichler HG, Abadie E, Breckenridge A, Leufkens H, Rasi G. Open clinical trial data for all? A view from
regulators. PLoS Med. 2012 Apr;9(4):e1001202. Epub 2012 Apr 10. PMID:22505851. PMCID:PMC3323505.
DOI:10.1371/journal.pmed.1001202.
[1901] Elizabeth Cohen. Lesson from Mom: Don't be 'good' patient. Empowered Patient, CNN. 2011 May 5.
[1902] Dr. Joseph Mercola. Now the FDA is Going After Vitamin C! Mercola.com, 2011 Jan 19.
http://articles.mercola.com/sites/articles/archive/2011/01/19/now-the-fda-is-going-after-vitamin-c.aspx
[1903] United States Army Institute of Surgical Research. The Effect of High Dose Vitamin C in Burn Patients.
Clinical trial identifier: NCT00350077. http://clinicaltrials.gov/ct2/show/NCT00350077
[1904] Matsuda T, Tanaka H, Yuasa H, Forrest R, Matsuda H, Hanumadass M, Reyes H. The effects of high-dose
vitamin C therapy on postburn lipid peroxidation. J Burn Care Rehabil. 1993 Nov-Dec;14(6):624-9.
PMID:8300697.
[1905] Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H, Shimazaki S. Reduction of resuscitation fluid
volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study. Arch
Surg. 2000 Mar;135(3):326-31. PMID:10722036. http://archsurg.ama-assn.org/cgi/content/full/135/3/326
[1906] Supplement basher Bjelakovic returns to the fray. Alliance for natural health, 2012 Apr 27. http://www.anheurope.org/news/supplement-basher-bjelakovic-returns-to-the-fray
[1907] Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of
mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012 Mar
14;3:CD007176. PMID:22419320. DOI:10.1002/14651858.CD007176.pub2.
[1908] Meck RA, Chen MS, Kenny PJ. Criteria for the administration of KI for thyroid blocking of radioiodine.
Health Phys. 1985 Feb;48(2):141-57. PMID:3882630.
[1909] Liekopisná komisia Štátneho ústavu pre kontrolu liečiv v Bratislave. Slovenský farmaceutický kódex 2007.
http://suklt.ui42.sk/buxus/docs//Posudzovanie_kvality_liekov/kodex2007.pdf
[1910] Miller KL, Coen PE, White WJ, Hurst WJ, Achey BE, Lang CM. Effectiveness of skin absorption of tincture
of I in blocking radioiodine from the human thyroid gland. Health Phys. 1989 Jun;56(6):911-4. PMID:2722514.
[1911] Miller KL, White WJ, Lang CM, Weidner WA. Skin exposure to I blocks thyroid uptake of 131I. Health Phys.
1985 Nov;49(5):791-4. PMID:4066341.
[1912] Anderson R. Ascorbate-mediated stimulation of neutrophil motility and lymphocyte transformation by
inhibition of the peroxidase/H2O2/halide system in vitro and in vivo. Am J Clin Nutr. 1981 Sep;34(9):1906-11.
PMID:7282616. http://www.ajcn.org/content/34/9/1906.long
[1913] Jungeblut CW. A further contribution to vitamin c therapy in experimental poliomyelitis. J Exp Med. 1939
Aug 31;70(3):315-32. PMID:19870912. PMCID:PMC2133810.
[1914] McCormick WJ. Poliomyelitis: vitamin b deficiency a possible factor in susceptibility. Can Med Assoc J.
1938 Mar;38(3):260-5. PMID:20320892. PMCID:PMC536391.
[1915] Delafuente JC, Panush RS. Modulation of certain immunologic responses by vitamin C. II. Enhancement of
concanavalin A-stimulated lymphocyte responses. Int J Vitam Nutr Res. 1980;50(1):44-51. PMID:7390715.
[1916] Anderson TW, Reid DB, Beaton GH. Vitamin C and the common cold: a double-blind trial. Can Med Assoc J.
1972 Sep 23;107(6):503-8. PMID:5057006. PMCID:PMC1940935.
[1917] Anderson R, Oosthuizen R, Maritz R, Theron A, Van Rensburg AJ. The effects of increasing weekly doses of
ascorbate on certain cellular and humoral immune functions in normal volunteers. Am J Clin Nutr. 1980
Jan;33(1):71-6. PMID:7355784. http://www.ajcn.org/content/33/1/71.long
[1918] Nungester WJ, Ames AM. The relationship between ascorbic acid and phagocytic activity. J Infect Dis. 1948
Jul-Aug;83(1):50-4. PMID:18869807. DOI:10.1093/infdis/83.1.50.
[1919] Long DA. Ascorbic acid and the production of antibody in the guinea-pig. Br J Exp Pathol. 1950
Apr;31(2):183-8. PMID:15434238. PMCID:PMC2073302.
[1920] Souto AB, Lima C. C R Soc Biol., Paris. 1938;129:763.
[1921] Catz J. C R Soc Biol., Paris. 1939;131:618.
[1922] Otani T. Orient J Dis Infants. 1939;25:1.
[1923] Büsing KH. Münch Med Wschr. 1939;86:575.
[1924] Büsing KH. Münch Med Wschr. 1939;86:822.
[1925] Jungeblut CW. J Infect Dis. 1941;69:70.
[1926] Willison FE. J Immunol. 1943;47:409.
[1927] Greenwald CH, Harde E. Proc Soc Exp Biol N Y. 1934-5;32:1157.
[1928] Bourne GH. Alkaline phosphatase and vitamin C deficiency in regeneration of skull bones. J Anat. 1948
Apr;82(Pt 1-2):81-7. PMID:17105048. PMCID:PMC1272960.
[1929] Bourne GH. Lancet. 1944;246:688.
[1930] Tonutti E, Matzner KH. Klin Wschr. 1938;17:63.
[1931] Zuskin E, Lewis AJ, Bouhuys A. Inhibition of histamine-induced airway constriction by ascorbic acid. J
Allergy Clin Immunol. 1973 Apr;51(4):218-26. PMID:4689139. l.